Keyword: Simcere Pharmaceutical
Amgen inked a biosim deal with Simcere, Gilead won a Chinese nod for Sovaldi, and Shanghai Pharma is in talks to buy part of Alvogen.
Amgen is expanding its cancer and inflammation biosimilar presence in China with a new deal with Simcere.
@FiercePharma: The U.S. taxman may come for pharma's foreign profits. Merck, J&J, Pfizer among those saving tax $$. Article | Follow @FiercePharma @EricPFierce: Baxter to cut 400 jobs in...